Joseph Carleone - 31 Dec 2025 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Issuer symbol
SXT
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
02 Jan 2026, 15:48:22 UTC
Previous filing
03 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carleone Joseph Director 777 EAST WISCONSIN AVENUE, MILWAUKEE /s/ John J. Manning, Attorney-in-Fact for Dr. Carleone 02 Jan 2026 0001212515

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SXT Common Stock 22,484 31 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SXT Deferred Stock Award $0 +389 +1.7% $0.000000 23,263 31 Dec 2025 Common Stock 389 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F2 Deferred stock converts to common stock on a one-for-one basis.
F3 Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
F4 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.